| 标题 |
[求助补充材料] [高分] Reasons for Discontinuation of Tezepelumab in a Real-world Cohort of Specialist-treated Asthma Patients
|
| 备注 |
求助海报,求助海报,请勿发摘要
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | The most common reason for discontinuation was a perceived lack of benefit, withlower raw FEV measurements significantly associated with discontinuation. The timetildiscontinuation varied, but those discontinuing for lack of benefit remained on treatment the longest.Cost is also a factor, with approximately 10% of patients who discontinue Tezepelumab due toexpense. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)